Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it. The COVID-19 virus has been named “SARS-CoV-2” (severe acute respiratory syndrome coronavirus 2) and the disease it causes has been named “Coronavirus Disease 2019” (COVID-19). The outbreak of the respiratory disease was first detected in Wuhan City, Hubei Province, China in Dec 2019. Life sciences companies are putting all of their efforts into finding a treatment or developing a vaccine for this disease. PharmaShots is keeping a track of all of the important updates in the Life-sciences sector, where we have covered news updates regarding collaborations, clinical trials, funding, and regulatory guidelines related to the COVID-19 from Jan to date.
Jul 30, 2020 | Clinical Trial
74. Sanofi and GSK Sign an Agreement with the UK Government to Supply ~60M Doses of COVID-19 Vaccine
Jul 29, 2020 | Collaboration
73. UK’s Recovery Continues to Test Roche’s Tocilizumab in COVID-19
Jul 29, 2020 | Clinical Trial
72. Roche’s Actemra/RoActemra Fails in COVID-19 Trial
Jul 29, 2020 | Clinical Trial
71. Green Cross’ GC5131A Receives the Regulatory Approval for P-II Trial for COVID-19
Jul 29, 2020 | Regulatory
Jul 29, 2020 | Regulatory
Jul 28, 2020 | Regulatory
Jul 28, 2020 | Clinical Trial
Jul 28, 2020 | Regulatory
66. Three Pharma Companies Launch Favipiravir to Treat COVID-19 in India
Jul 27, 2020 | Launch
Jul 27, 2020 | Collaboration
Jul 27, 2020 | Clinical Trial
63. Zydus to Initiate Clinical Study of Desidustat in Patients with Chemotherapy-Induced Anemia (CIA)
July 24, 2020 | Clinical Trial
Jul 27, 2020 | Clinical Trial
61. The UK Government to Launch AbC-19 Lateral Flow Free Finger-Prick Test for COVID-19
Jul 27, 2020 | Launch
60. Mylan Launches Remdesivir Under the Brand Name Desrem for COVID-19 in India
Jul 27, 2020 | Launch
59. Pfizer and BioNTech Elicits Strong T-cell Response in P-I/II Study Against COVID-19
Jul 27, 2020 | Clinical Trial
Jul 27, 2020 | Clinical Trial
57. Quest Diagnostic Receives the US FDA’s First EUA for Sample Pooling in COVID-19
Jul 20, 2020 | Diagnostic
56. Celltrion Initiates P-I Study of its COVID-19 Antibody Treatment in South Korea
Jul 20, 2020 | Clinical Trial
55. Zydus Initiates Adaptive P-I/II Clinical Study Evaluating its ZyCoV-D Against COVID-19 in India
Jul 16, 2020 | Clinical Trial
54. Novartis Launches Zero Profit Portfolio for Symptomatic Treatment of COVID-19
Jul 16, 2020 | Launch
53. AstraZeneca and the University of Oxford to Share Positive News on its COVID-19 Vaccine Imminently
Jul 15, 2020 | Collaboration
52. 3M Collaborates with MIT to Develop Paper-Based Diagnostic Test for COVID-19
Jul 13, 2020 | Collaboration
51. Moderna to Commence Late-stage COVID-19 Vaccine Trial on 27 July, 2020
Jul 13, 2020 | Clinical Trial
50. The International Fencing Federation (FIE) Reports the Global COVID-19 Support Plan
July 13, 2020 | Launch
Jul 12, 2020 | Regulatory
48. The Zimbabwe Government to Launch US $10M COVID-19 Relief Package
Jul 11, 2020 | Launch
Jul 10, 2020 | Regulatory
46. AstraZeneca Collaborates with ProteinQure to Design Novel Peptide Therapeutics
Jul 10, 2020 | Collaboration
45. Cipla Launches Cipremi at $53.34 per Vial in India
Jul 10, 2020 | Launch
44. The Health Ministry of Kyrgyzstan Reports Supply of Avifavir an Antiviral Drug form Russia
Jul 09, 2020 | Regulatory
43. Regeneron Signs an Agreement with BARDA and the US Department of Defense for REGN-COV2 Worth $450M
Jul 08, 2020 | Clinical Trial
Jul 08, 2020 | Clinical Trial
Jul 09, 2020 | Collaboration
40. GSK and Medicago to Initiate P-I Trial of Plant-Based COVID-19 Vaccine in July 2020
Jul 08, 2020 | Clinical Trial
39. Regeneron Signs an Agreement with BARDA and the US Department of Defense for REGN-COV2 Worth $450M
Jul 08, 2020 | Collaboration
38. Innovation Pharmaceuticals Reports Results Brilacidin in COVID-19 Clinical Trial
Jul 07, 2020 | Clinical Trial
37. Reven Reports Publication of Two COVID-19 Articles for RJX Platform
Jul 07, 2020 | Regulatory
Jul 07, 2020 | Collaboration
35. Constant Therapeutics’ TXA127 will be Evaluated in P-II Trial for COVID-19 Patients
Jul 07, 2020 | Clinical Trial
34. Sinovac’s P-III COVID-19 Trial Receives the Brazilian Regulator Approval
Jul 07, 2020 | Regulatory
33. Nasus Pharma Reports Results of TaffiX as a Intranasal Antiviral Protection Against SARS-CoV-2
Jul 07, 2020 | Clinical Trial
32. Mylan Receives EUA Approval for its Remdesivir to Treat COVID-19
Jul 07, 2020 | Regulatory
Jul 07, 2020 | Clinical Trial
30. Novavax to Receive $1.6B Funds from the US
Jul 07, 2020 | Grants
29. Aboundbio Signs an Agreement with SaudiVax for COVID-19
Jul 07, 2020 | Collaboration
28. Hepion Pharmaceuticals Reports Preclinical Results of CRV431 for Treating COVID-19
Jul 07, 2020 | Clinical Trial
Jul 07, 2020 | Clinical Trial
Jul 06, 2020 | Clinical Trial
Jul 06, 2020 | Regulatory
24. Zydus to Initiate Clinical Trials Evaluating ZyCoV-D Vaccine Against COVID-19 in July 2020
Jul 03, 2020 | Clinical Trial
23. Sanofi and Regeneron’s Kevzara (sarilumab) Fails in P-III Trial for Patients with COVID-19 in the US
Jul 03, 2020 | Clinical Trial
22. Moderna Reports the Enrollment of P-II Trial for its mRNA-1273 to Treat COVID-19
Jul 03, 2020 | Clinical Trial
21. Sorrento Selects T-VIVA-19 as a Targeted Protein Vaccine Candidate Against COVID-19
Jul 02, 2020 | Clinical Trial
Jul 02, 2020 | Collaboration
19. Pfizer and BioNTech Report Results of BNT162b1 mRNA-Based Vaccine in P-I/II Study Against COVID-19
Jul 02, 2020 | Clinical Trial
18. Zydus to Initiate Clinical Trials Evaluating ZyCoV-D Vaccine Against COVID-19 in July 2020
Jul 03, 2020 | Clinical Trial
17. Sanofi and Regeneron’s Kevzara (sarilumab) Fails in P-III Study for Patients with COVID-19 in the US
Jul 02, 2020 | Clinical Trial
16. Phase II Study of MRx-4DP0004 in Patients Hospitalized with COVID-19 Open for Enrolment
Jul 02, 2020 | Clinical Trial
15. Regulatory Authorities Step Up Cooperation in Connection with COVID-19
Jul 02, 2020 | Regulatory
14. Austria Donates €2M to CEPI to Support COVID-19 Vaccine Programmes
Jul 02, 2020 | Grant
13. Liminal BioSciences Joins CoVIg Plasma Alliance to Develop New COVID-19 Therapy
Jul 02, 2020 | Collaboration
Jul 02, 2020 | Clinical Trial
Jul 02, 2020 | Clinical Trial
10. Moderna Faces Delay in its COVID-19 Vaccine Trial
Jul 02, 2020 | Clinical Trial
9. Anivive Initiates Two Pre-Clinical Studies of GC376 for the Treatment of COVID-19
Jul 02, 2020 | Clinical Trial
Jul 01, 2020 | Clinical Trial
7. GoldenBiotech’s Antroquinonol Receives FDA Approval on COVID-19 P-II Trial in the US
Jul 01, 2020 | Regulatory
6. New Study Highlights Senhwa Biosciences Silmitasertib as Potential Treatment for COVID-19
Jul 01, 2020 | Clinical Trial
5. International Regulators Provide Guiding Principles for COVID-19 Clinical Trials
Jul 01, 2020 | Regulatory
4. FibroGenesis Identifies Mechanism Responsible for Blocking COVID19-Like Lung Inflammation
Jul 01, 2020 | Clinical Trial
3. Inimmune Awarded $2M SBIR to Advance Vaccine Technologies
Jul 01, 2020 | Grant
Jul 01, 2020 | Clinical Trial
1. FAMHP Facilitates and Supports the Development of COVID-19 Treatments and Vaccines
Jul 01, 2020 | Regulatory
Nec ut tellus ornare, orci tortor suspendisse aliquet sollicitudin rhoncus, maecenas suscipit cras porttitor vestibulum vivamus.
Neque turpis vitae eros praesent varius. Egestas pellentesque urna blandit, sed ac leo ut mi, nam wisi, laborum donec erat amet.
Massa suspendisse lorem turpis ac. Pellentesque volutpat faucibus pellentesque velit in, leo odio molestie, magnis vitae condimentum.
Aute mi ut suspendisse velit leo, vel risus ac. Amet dui dignissim fermentum malesuada auctor volutpat, vestibulum ipsum nulla.